Articles Archives - Page 218 of 785

ThursdayJul 13, 2023 9:00 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) RapidSX(TM) Technology Offers Best Solution for Current and Possible Future Chinese Export Restrictions

China has demonstrated their intension to weaponize access to critical metals, with restrictions on germanium and gallium scheduled for August, and rare earth metals used in permanent magnets could be next China accounts for 90% of the gallium and 80% of the germanium supply exports used in the United States and other European countries Gallium and germanium are two materials important for the production of semiconductor chips, and China’s control of the market makes it exceedingly difficult for secure production without a North American supply Ucore’s RapidSX(TM) technology utilizes similar chemistry to conventional SX and significantly improves the well-established, well-understood,…

WednesdayJul 12, 2023 9:45 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Sees Hot Market Potential for NanoAb Pipeline

The global dermatology pharmaceutics market is booming, with increased public awareness and large unmet needs BiondVax competitor MoonLake Immunotherapeutics share price jumped 128% after positive findings from a Phase 2 trial evaluating Nanobody(R) sonelokimab in patients with moderate-to-severe hidradenitis suppurativa, a painful long-term dermatological condition BiondVax’s NanoAbs address psoriasis and a broad range of other diseases, and with a potentially better safety profile based on administration directly into lesions, rather than MoonLake’s systemic-administration The global dermatology pharmaceutics market was valued just over $20 billion in 2022 and is expected to surge to nearly $40 billion by 2030, growing at a…

WednesdayJul 12, 2023 9:00 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) 2023 PEA’s Proposed Base Case Development Strategy Expected to Measurably Reduce Environmental Impact of Mining Operations at Los Azules Project

McEwen Mining, an asset-rich diversified gold and copper producer that owns a 52% stake in McEwen Copper, recently released the results of an updated Preliminary Economic Assessment (“2023 PEA”) The 2023 PEA documented, among others, an updated independent mineral resource estimate and a base case development strategy that is distinctly different from that proposed in the 2017 PEA The recent PEA proposes the development of an open pit mine with crushing, heap leaching, and solvent extraction and electrowinning (“SW/EW”) facilities to process the mined materials, producing copper cathodes that meet LME Copper Grade A quality standards The updated development strategy…

TuesdayJul 11, 2023 9:45 am

Starco Brands, Inc. (STCB) Partners with AMC to Launch Cardi B’s Whipshots(R) at 250+ Theatres Nationwide

Starco Brands partners with AMC to offer Whipshots(R) Vanilla or Lime flavors to cocktails at 250+ theatres across the United States Partnership to include “Whip It, Beaches” campaign spot before selected films and imagery throughout theaters Whipshots earned several awards, including Beverage Dynamics’ 2023 “Rising Star Award”, 2023 SIP Innovation Award, and four medals at the DB & SB Spring Blind Tasting segment of the 2023 Global Spirits Masters Competition Starco Brands 2022 year-end financial statements revealed a 1,060% revenue increase to $7.8 million Other Starco Brands products include Kobe Bryant’s Art of Sport premium athletic body care line, Skylar…

TuesdayJul 11, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) – A Zacks Update

Lexaria just released its mid-year update, highlighting its key milestones so far and its objectives going forward, summarized in a recent Zacks update Of note was the company’s most ambitious clinical study yet, HYPER-H21-4, along with its growing patent portfolio that now sees six additional patents awarded across Australia, Japan, the U.S., and Canada so far in 2023 The company also noted its $2 million capital raise back in May, a strong indicator of shareholders’ confidence in the brand, and its efforts to grow its operations Lexaria looks to build on the momentum gathered so far, and its management is…

MondayJul 10, 2023 11:15 am

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Is ‘One to Watch’

First Tellurium in June 2023 successfully uplisted from the OTC Pink Market to the OTCQB Venture Market First Tellurium has contracted for IP geophysics on its Deer Horn Project during summer 2023 to develop targets for a drilling program The company has engaged consultants to stake additional claims around its Klondike gold-tellurium project in Colorado Key applications for tellurium include high efficiency cadmium telluride solar panels, next-gen lithium-ion batteries, semiconductors, thermoelectric devices, phase-change memory chips and low-energy desalination The company plans to investigate and acquire other tellurium projects in North America First Tellurium (CSE: FTEL) (OTCQB: FSTTF) is committed to…

MondayJul 10, 2023 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Technology Ready to Answer Call of Proposed Legislation for Near-Term Quantum Applications to Solve Optimization Problems

Legislation presented to Congress calls for the United States government to develop and adopt near-term quantum computing – some within 24 months or less for developing and deploying demos, proofs of concepts, and pilots Global government spending on quantum application development is expected to reach $36 billion during 2023 D-Wave offers quantum solutions to help government and public sector develop applications that can solve important optimization problems Recent legislation presented to Congress calls for the United States government to develop and adopt near-term quantum computing applications to solve complex public sector optimization problems, which could include electrical grid resilience, optimization…

MondayJul 10, 2023 9:45 am

Data443 Risk Mitigation Inc. (ATDS) Upgrades Product Offering; Committed to Enabling Businesses to Manage Data Privacy in Cloud, Hybrid Environments

Data is one of the most valuable and critical assets for today's businesses, but with cyber-attacks on the rise it can quickly become one of their greatest liabilities Alarming statistics reveal that the number of security executives reporting security incidents in software-as-a-service environments surged from 43% to 55% over the past two years, with data leakage as the most common type of security incident, followed by malicious apps, data breaches, and ransomware Amid the current climate of ongoing data breach news, Data443 Risk Mitigation aims to cement its position as the provider of "All Things Data Security" by continuing to…

MondayJul 10, 2023 9:00 am

Genprex Inc. (NASDAQ: GNPX) Reports Positive Results from its Phase 1 Acclaim-1 Clinical Trial; Releases Patient Video Describing Positive Experience

Genprex recently announced that its lead drug candidate, REQORSA(R), was well tolerated with no dose-limiting toxicities in the Phase 1 portion of its Acclaim-1 clinical trial The Phase 1 clinical data were added to by the release of a new patient video highlighting a patient’s experience with REQORSA. This patient has now been on the Acclaim-1 trial without disease progression for one year The Safety Review Committee approved the advancement of the Acclaim 1 clinical trial to the Phase 2 expansion portion of the trial Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients…

Site Search

Company Search

Category: Articles